At a meeting of the NIBSC Infectious Hazards of Blood Products, it was noted that the anti-hepatitis B core antibody was positive in more than 90% of AIDS cases in the US. However, there was no agreement that testing for the Hepatitis B core antibody should be included in routine screening of all donors.